Publication | Closed Access

Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial

Chemotherapy Versus PlaceboGastrointestinal OncologyMedicineClinical TrialsImmune Checkpoint InhibitorPharmacotherapyGastric CancerCancer TreatmentOncologyRadiation OncologyHealth Sciences